Related references
Note: Only part of the references are listed.Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration
Tara E. Tracy et al.
CELL (2022)
Intrinsic and acquired drug resistance to LSD1 inhibitors in small cell lung cancer occurs through a TEAD4-driven transcriptional state
Wen Yan et al.
MOLECULAR ONCOLOGY (2022)
BRD4-directed super-enhancer organization of transcription repression programs links to chemotherapeutic efficacy in breast cancer
Beibei Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Activation of ABCC Genes by Cisplatin Depends on the CoREST Occurrence at Their Promoters in A549 and MDA-MB-231 Cell Lines
Maciej Sobczak et al.
CANCERS (2022)
Role of Lysine-specific Demethylase 1 and Its Small Molecule Inhibitors in Glioblastoma Multiforme Therapy
Rangan Mitra et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2022)
Small-cell breast carcinoma with response to atezolizumab: a case report
Nicholas Stimes et al.
IMMUNOTHERAPY (2022)
Structure-Activity Relationship Study of Indolin-5-yl-cyclopropanamine Derivatives as Selective Lysine Specific Demethylase 1 (LSD1) Inhibitors
Chunpu Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Biological Activities of Natural Products II
Halina Maria Ekiert et al.
MOLECULES (2022)
Targeting the lysine-specific demethylase 1 rewires kinase networks and primes leukemia cells for kinase inhibitor treatment
Federico Pedicona et al.
SCIENCE SIGNALING (2022)
Histone lysine demethylases and their functions in cancer
Jayden Sterling et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Arborinine, a potential LSD1 inhibitor, inhibits epithelial-mesenchymal transition of SGC-7901 cells and adriamycin-resistant gastric cancer SGC-7901/ADR cells
Yafei Chu et al.
INVESTIGATIONAL NEW DRUGS (2021)
MEK inhibitors for the treatment of non-small cell lung cancer
Jing Han et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Pharmacological inhibition of KDM5A for cancer treatment
Guan-Jun Yang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements
Shang-Min Zhang et al.
NATURE (2021)
LSD1-directed therapy affects glioblastoma tumorigenicity by deregulating the protective ATF4-dependent integrated stress response
Stefania Faletti et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Simultaneous Inhibition of LSD1 and TGFβ Enables Eradication of Poorly Immunogenic Tumors with Anti-PD-1 Treatment
Wanqiang Sheng et al.
CANCER DISCOVERY (2021)
Targeting LSD1 suppresses stem cell-like properties and sensitizes head and neck squamous cell carcinoma to PD-1 blockade
Yong Han et al.
CELL DEATH & DISEASE (2021)
LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade
Yi Liu et al.
NATURE COMMUNICATIONS (2021)
Epigenetic Remodeling Hydrogel Patches for Multidrug-Resistant Triple-Negative Breast Cancer
Xiaoyuan Ji et al.
ADVANCED MATERIALS (2021)
Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer
Ying-Chao Duan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
MLL5 improves ATRA driven differentiation and promotes xenotransplant engraftment in acute promyelocytic leukemia model
Diego A. Pereira-Martins et al.
CELL DEATH & DISEASE (2021)
GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer
Camilla Pecoraro et al.
DRUG RESISTANCE UPDATES (2021)
Design, synthesis and biological evaluation of novel benzofuran derivatives as potent LSD1 inhibitors
Xiangyu Zhang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
LSD1-Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1-Induced p62 Transcription in HCC
Luyuan Ma et al.
HEPATOLOGY (2021)
Angiogenesis and chemotherapy resistance: optimizing chemotherapy scheduling using mathematical modeling
Mariusz Bodzioch et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Management of chemotherapy side effects and their long-term sequelae
Isabella M. Zraik et al.
UROLOGE (2021)
CBP/p300 Bromodomain Inhibitor-I-CBP112 Declines Transcription of the Key ABC Transporters and Sensitizes Cancer Cells to Chemotherapy Drugs
Magdalena Strachowska et al.
CANCERS (2021)
Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells
Warren Fiskus et al.
BLOOD CANCER JOURNAL (2021)
EGFR-mediated autophagy in tumourigenesis and therapeutic resistance
Min Wu et al.
CANCER LETTERS (2020)
The IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomas
Ricardo Gargini et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Exploration of 5-cyano-6-phenylpyrimidin derivatives containing an 1,2,3-triazole moiety as potent FAD-based LSD1 inhibitors
Liying Ma et al.
ACTA PHARMACEUTICA SINICA B (2020)
The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes
Elisabet Cuyas et al.
AGING-US (2020)
Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis
Sima Lev
BIOCHEMICAL SOCIETY TRANSACTIONS (2020)
Acquired Resistance to Immune Checkpoint Inhibitors
Adam J. Schoenfeld et al.
CANCER CELL (2020)
Defining and Targeting Adaptations to Oncogenic KRASG12C Inhibition Using Quantitative Temporal Proteomics
Naiara Santana-Codina et al.
CELL REPORTS (2020)
Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies
Yu-Chin Liu et al.
CELLS (2020)
Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma
Wen-Bin Yang et al.
NEURO-ONCOLOGY (2020)
E2F1-induced ferritin heavy chain 1 pseudogene 3 (FTH1P3) accelerates non-small cell lung cancer gefitinib resistance
Guanying Zheng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch
Wen Juan Tu et al.
FRONTIERS IN IMMUNOLOGY (2020)
LSD1 inhibition in pHGG: the key to unleashing immunotherapy?
Theodore P. Nicolaides et al.
NEURO-ONCOLOGY (2020)
The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer
Raffaella Soldi et al.
PLOS ONE (2020)
First-in-Human Phase I Study of ladademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia
Olga Salamero et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Histone methyltransferase and drug resistance in cancers
Cheng Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective
Xing-Jie Dai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer
Shuai Gao et al.
NATURE GENETICS (2020)
c-myc regulates the sensitivity of breast cancer cells to palbociclib via c-myc/miR-29b-3p/CDK6 axis
Wenfei Ji et al.
CELL DEATH & DISEASE (2020)
CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5-LSD1-NF-κB oncogenic signaling
Bo Hu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Synergistic antitumor effect of 5-fluorouracil with the novel LSD1 inhibitor ZY0511 in colorectal cancer
Wen Peng et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
The inhibition of LSD1 via sequestration contributes to tau-mediated neurodegeneration
Amanda K. Engstrom et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications
Huibin Song et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Knocking down LSD1 inhibits the sternness features of colorectal cancer stern cells
J. Chen et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2020)
KDM5 demethylases and their role in cancer cell chemoresistance
Johana Plch et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade
Ye Qin et al.
ONCOGENE (2019)
Suppression of LSD1 enhances the cytotoxic and apoptotic effects of regorafenib in hepatocellular carcinoma cells
Lin-wen Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade
Brian C. Miller et al.
NATURE IMMUNOLOGY (2019)
Inhibition of lysine-specific demethylase LSD1 induces senescence in Glioblastoma cells through a HIF-1α-dependent pathway
Carmen D. Sacca et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2019)
Molecular insights into cancer drug resistance from a proteomics perspective
Yao An et al.
EXPERT REVIEW OF PROTEOMICS (2019)
Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: A case report
Tomoyuki Naito et al.
THORACIC CANCER (2019)
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia
Charles C. Bell et al.
NATURE COMMUNICATIONS (2019)
Lysine-Specific Histone Demethylase 1A Regulates Macrophage Polarization and Checkpoint Molecules in the Tumor Microenvironment of Triple-Negative Breast Cancer
Abel H. Y. Tan et al.
FRONTIERS IN IMMUNOLOGY (2019)
The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML
Melanie Kahl et al.
LEUKEMIA (2019)
Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG
Jamie N. Anastas et al.
CANCER CELL (2019)
Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis
Scott J. Antonia et al.
LANCET ONCOLOGY (2019)
The Histone Demethylase LSD1/KDM1A Mediates Chemoresistance in Breast Cancer via Regulation of a Stem Cell Program
John Verigos et al.
CANCERS (2019)
LSD1/KDM1A, a Gate-Keeper of Cancer Stemness and a Promising Therapeutic Target
Panagiotis Karakaidos et al.
CANCERS (2019)
Knockdown of long non-coding HOTAIR enhances the sensitivity to progesterone in endometrial cancer by epigenetic regulation of progesterone receptor isoform B
Shuqi Chi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p
Guodong Ma et al.
DNA AND CELL BIOLOGY (2019)
Outcome of EGFR-mutated adenocarcinoma NSCLC patients with changed phenotype to squamous cell carcinoma after tyrosine kinase inhibitors: A pooled analysis with an additional case
Elisa Roca et al.
LUNG CANCER (2019)
Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
Catherine Lee et al.
NATURE COMMUNICATIONS (2019)
Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast Cancer
Rosaria Benedetti et al.
CANCERS (2019)
Broad-spectrum Preclinical Antitumor Activity of Eribulin (Halaven®): Combination with Anticancer Agents of Differing Mechanisms
Makoto Asano et al.
ANTICANCER RESEARCH (2018)
ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia
Tamara Maes et al.
CANCER CELL (2018)
LSD1 inhibition attenuates androgen receptor V7 splice variant activation in castration resistant prostate cancer models
Sergio Regufe da Mota et al.
CANCER CELL INTERNATIONAL (2018)
Chemoresistance Evolution in Triple-Negative Breast Cancer Delineated by Single-Cell Sequencing
Charissa Kim et al.
CELL (2018)
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
Wanqiang Sheng et al.
CELL (2018)
LSD1 demethylase and the methyl-binding protein PHF20L1 prevent SET7 methyltransferase-dependent proteolysis of the stem-cell protein SOX2
Chunxiao Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Discovery of 5-Cyano-6-phenylpyrimidin Derivatives Containing an Acylurea Moiety as Orally Bioavailable Reversal Agents against P-Glycoprotein-Mediated Mutidrug Resistance
Bo Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
Hypoxia Promotes Resistance to EGFR Inhibition in NSCLC Cells via the Histone Demethylases, LSD1 and PLU-1
Yuhong Lu et al.
MOLECULAR CANCER RESEARCH (2018)
PKCα-LSD1-NF-κB-Signaling Cascade Is Crucial for Epigenetic Control of the Inflammatory Response
Dongha Kim et al.
MOLECULAR CELL (2018)
The HER4-YAP1 axis promotes trastuzumab resistance in HER2-positive gastric cancer by inducing epithelial and mesenchymal transition
Jiaolong Shi et al.
ONCOGENE (2018)
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors
Jay H. Kalin et al.
NATURE COMMUNICATIONS (2018)
LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer
T. Boulding et al.
SCIENTIFIC REPORTS (2018)
EZH2-Mediated Epigenetic Suppression of GDF15 Predicts a Poor Prognosis and Regulates Cell Proliferation in Non-Small-Cell Lung Cancer
Xiyi Lu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Pharmacological inhibition of LSD1 activity blocks REST-dependent medulloblastoma cell migration
Keri Callegari et al.
CELL COMMUNICATION AND SIGNALING (2018)
Preclinical studies reveal that LSD1 inhibition results in tumor growth arrest in lung adenocarcinoma independently of driver mutations
Iris F. Macheleidt et al.
MOLECULAR ONCOLOGY (2018)
KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance
Kunihiko Hinohara et al.
CANCER CELL (2018)
Pharmacological Inhibition of LSD1 for Cancer Treatment
Guan-Jun Yang et al.
MOLECULES (2018)
Controlled drug delivery vehicles for cancer treatment and their performance
Sudipta Senapati et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
The diverse functions of the PD1 inhibitory pathway
Arlene H. Sharpe et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway
G. R. Sareddy et al.
ONCOGENE (2017)
Advances toward LSD1 inhibitors for cancer therapy
Xiaoli Fu et al.
FUTURE MEDICINAL CHEMISTRY (2017)
UTX promotes hormonally responsive breast carcinogenesis through feed-forward transcription regulation with estrogen receptor
G. Xie et al.
ONCOGENE (2017)
The H3K27me3-demethylase KDM6A is suppressed in breast cancer stem-like cells, and enables the resolution of bivalency during the mesenchymal-epithelial transition
Joseph H. Taube et al.
ONCOTARGET (2017)
EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression
Arun Satelli et al.
ONCOTARGET (2017)
LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC)
Rong He et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Targeting KDM1A attenuates Wnt/β-catenin signaling pathway to eliminate sorafenib-resistant stem-like cells in hepatocellular carcinoma
Mengxi Huang et al.
CANCER LETTERS (2017)
Writing, erasing and reading histone lysine methylations
Kwangbeom Hyun et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells
Donatella Fiore et al.
CANCER BIOLOGY & THERAPY (2016)
ATP-binding cassette transporters in reproduction: a new frontier
E. Bloise et al.
HUMAN REPRODUCTION UPDATE (2016)
CACUL1 functions as a negative regulator of androgen receptor in prostate cancer cells
Hanbyeul Choi et al.
CANCER LETTERS (2016)
The histone demethylase LSD1 is a novel oncogene and therapeutic target in oral cancer
Yanling Wang et al.
CANCER LETTERS (2016)
The growing structural and functional complexity of the LSD1/KDM1A histone demethylase
Chiara Marabelli et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2016)
Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment
Yi C. Zheng et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Recent Progress in Histone Demethylase Inhibitors
Tom E. McAllister et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells
Maia Vinogradova et al.
NATURE CHEMICAL BIOLOGY (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
LSD1 engages a corepressor complex for the activation of the estrogen receptor α by estrogen and cAMP
Marcela A. Bennesch et al.
NUCLEIC ACIDS RESEARCH (2016)
Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells
S. Gupta et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2016)
Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines
Maria Pinkerneil et al.
TARGETED ONCOLOGY (2016)
Methylation-dependent regulation of HIF-1 alpha stability restricts retinal and tumour angiogenesis
Yunho Kim et al.
NATURE COMMUNICATIONS (2016)
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Konstantinos Tzelepis et al.
CELL REPORTS (2016)
Safety, Phamacokinetics (PK), Pharmacodynamics (PD) and Preliminary Activity in Acute Leukemia of Ory-1001, a First-in-Class Inhibitor of Lysine-Specific Histone Demethylase 1A (LSD1/KDM1A): Initial Results from a First-in-Human Phase 1 Study
Tim Somervaille et al.
BLOOD (2016)
Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence
Yuichiro Miyoshi et al.
BREAST CANCER RESEARCH (2016)
Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression Of prostate cancer in vivo
Min Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Regulation of the p53 response and its relationship to cancer
David W. Meek
BIOCHEMICAL JOURNAL (2015)
KDM1 Class Flavin-Dependent Protein Lysine Demethylases
Jonathan M. Burg et al.
BIOPOLYMERS (2015)
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Edgar Perez-Herrero et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
BET inhibitor resistance emerges from leukaemia stem cells
Chun Yew Fong et al.
NATURE (2015)
Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5+ liver cancer initiating cells by suppressing negative regulators of β-catenin signaling
Z-J Lei et al.
ONCOGENE (2015)
Lysine-specific demethylase 1 mediates epidermal growth factor signaling to promote cell migration in ovarian cancer cells
Genbao Shao et al.
SCIENTIFIC REPORTS (2015)
Integrated network model provides new insights into castration-resistant prostate cancer
Yanling Hu et al.
SCIENTIFIC REPORTS (2015)
Glioma
Michael Weller et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Reprogramming Using microRNA-302 Improves Drug Sensitivity in Hepatocellular Carcinoma Cells
Chikato Koga et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Unlocking the potential of retinoic acid in anticancer therapy
T. Schenk et al.
BRITISH JOURNAL OF CANCER (2014)
Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
Qiong Wu et al.
CANCER LETTERS (2014)
Chromatin Repressive Complexes in Stem Cells, Development, and Cancer
Anne Laugesen et al.
CELL STEM CELL (2014)
Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine-Specific Demethylases Display High Anticancer Activities
Dante Rotili et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells
W. Fiskus et al.
LEUKEMIA (2014)
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Retinoic acid impairs estrogen signaling in breast cancer cells by interfering with activation of LSD1 via PKA
Maria Neve Ombra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2013)
Progesterone Action in Endometrial Cancer, Endometriosis, Uterine Fibroids, and Breast Cancer
J. Julie Kim et al.
ENDOCRINE REVIEWS (2013)
Negative regulation of ERα by a novel protein CAC1 through association with histone demethylase LSD1
JuHyun Kim et al.
FEBS LETTERS (2013)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
Regulatory networks defining EMT during cancer initiation and progression
Bram De Craene et al.
NATURE REVIEWS CANCER (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
Joshua C. Black et al.
MOLECULAR CELL (2012)
Glioma Stem Cells: Their Role in Chemoresistance
Ryosuke Yamada et al.
WORLD NEUROSURGERY (2012)
Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
Valerie Cortez et al.
BREAST CANCER RESEARCH (2012)
Binding of the JmjC Demethylase JARID1B to LSD1/NuRD Suppresses Angiogenesis and Metastasis in Breast Cancer Cells by Repressing Chemokine CCL14
Qian Li et al.
CANCER RESEARCH (2011)
Prognostic Importance of Histone Methyltransferase MLL5 Expression in Acute Myeloid Leukemia
Frederik Damm et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors
Melissa M. Singh et al.
NEURO-ONCOLOGY (2011)
Regulation of somatic cell reprogramming through inducible mir-302 expression
Shi-Lung Lin et al.
NUCLEIC ACIDS RESEARCH (2011)
Progesterone Receptor-B Induction of BIRC3 Protects Endometrial Cancer Cells from AP1-59-Mediated Apoptosis
Nikki L. Neubauer et al.
Hormones & Cancer (2011)
p-Glycoprotein ABCB5 and YB-1 expression plays a role in increased heterogeneity of breast cancer cells: correlations with cell fusion and doxorubicin resistance
Ji Yeon Yang et al.
BMC CANCER (2010)
Snail regulates cell survival and inhibits cellular senescence in human metastatic prostate cancer cell lines
Modjtaba Emadi Baygi et al.
CELL BIOLOGY AND TOXICOLOGY (2010)
PELP1 is a reader of histone H3 methylation that facilitates oestrogen receptor-α target gene activation by regulating lysine demethylase 1 specificity
Sujit S. Nair et al.
EMBO REPORTS (2010)
Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells
Meng-Lei Zhu et al.
FASEB JOURNAL (2010)
CARM1 mediates the ligand-independent and tamoxifen-resistant activation of the estrogen receptor α by cAMP
Sophie Carascossa et al.
GENES & DEVELOPMENT (2010)
Biochemical, Structural, and Biological Evaluation of Tranylcypromine Derivatives as Inhibitors of Histone Demethylases LSD1 and LSD2
Claudia Binda et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription
S. Amente et al.
ONCOGENE (2010)
LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer
Yan Wang et al.
CELL (2009)
The Emerging Therapeutic Potential of Histone Methyltransferase and Demethylase Inhibitors
Astrid Spannhoff et al.
CHEMMEDCHEM (2009)
Identification of Cell-Active Lysine Specific Demethylase 1-Selective Inhibitors
Rie Ueda et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Mechanisms involved in the regulation of histone lysine demethylases
Fei Lan et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics
Mark S. Cragg et al.
PLOS MEDICINE (2007)
p53 is regulated by the lysine demethylase LSD1
Jing Huang et al.
NATURE (2007)
Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine
Maojun Yang et al.
BIOCHEMISTRY (2007)
Regulation of histone methylation by demethylimination and demethylation
Robert J. Klose et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Biologic basis of sequential and combination therapies for hormone-responsive breast cancer
Richard J. Pietras
ONCOLOGIST (2006)
Solution structure of the SWIRM domain of human histone demethylase LSD1
N Tochio et al.
STRUCTURE (2006)
Histone demethylation mediated by the nuclear arnine oxidase homolog LSD1
YJ Shi et al.
CELL (2004)
Antibacterial activity and cytotoxicity of extractives from Ravenia spectabilis
MH Sohrab et al.
FITOTERAPIA (2004)
Share Paper
